The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
Open accessAbstract
The synthetic peptides DP-107 and DP-178 (T-20), derived from separate domains within the human immunodeficiency virus type 1 (HIV-1) transmembrane (TM) protein, gp4l, are stable and potent inhibitors of HIV-1 infection and fusion. Using a computer searching strategy (computerized antiviral searching technology, C.A.S.T.) based on the predicted secondary structure of DP-107 and DP-178 (T-20), we have identified conserved heptad repeat domains analogous to the DP-107 and DP-178 regions of HIV-1 gp41 within the glycoproteins of other fusogenic viruses. Here we report on antiviral peptides derived from three representative paramyxoviruses, respiratory syncytial virus (RSV), human parainfluenza virus type 3 (HPIV-3), and measles virus (MV). We screened crude preparations of synthetic 35-residue peptides, scanning the DP-178-like domains, in antiviral assays. Peptide preparations demonstrating antiviral activity were purified and tested for their ability to block syncytium formation. Representative DP-178-like peptides from each paramyxovirus blocked homologous virus-mediated syncytium formation and exhibited EC50 values in the range 0.015-0.250 microM. Moreover, these peptides were highly selective for the virus of origin. Identification of biologically active peptides derived from domains within paramyxovirus F1 proteins analogous to the DP-178 domain of HIV-1 gp4l is compelling evidence for equivalent structural and functional features between retroviral and paramyxoviral fusion proteins. These antiviral peptides provide a novel approach to the development of targeted therapies for paramyxovirus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
FIELDS, G. B., & NOBLE, R. L. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,493
Wilschut, J. (1990) · Cited by 2,407
Structure of influenza haemagglutinin at the pH of membrane fusion
Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994) · Nature · doi:10.1038/371037a0 · Cited by 1,564
Scheid, A., & Choppin, P. W. (1974) · Virology · doi:10.1016/0042-6822(74)90187-1 · Cited by 911
A spring-loaded mechanism for the conformational change of influenza hemagglutinin
Carr, C. M., & Kim, P. S. (1993) · Cell · doi:10.1016/0092-8674(93)90260-w · Cited by 857
A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis
KING, D. S., FIELDS, C. G., & FIELDS, G. B. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00976.x · Cited by 725
Weislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H., & Boyd, M. R. (1989) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.577 · Cited by 685
White, J. M. (1992) · Science · doi:10.1126/science.1439803 · Cited by 628
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
Viral and Cellular Membrane Fusion Proteins
White, J. M. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.003331 · Cited by 522
Cited by
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Bosch, B. J., van der Zee, R., de Haan, C. A. M., & Rottier, P. J. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8801-8811.2003 · Cited by 1,489
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Henrickson, K. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.242-264.2003 · Cited by 498
Capture of an early fusion-active conformation of HIV-1 gp41
Furuta, R. A., Wild, C. T., Weng, Y., & Weiss, C. D. (1998) · Nature Structural Biology · doi:10.1038/nsb0498-276 · Cited by 488
Hendra and Nipah viruses: different and dangerous
Eaton, B. T., Broder, C. C., Middleton, D., & Wang, L.-F. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1323 · Cited by 482
Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
Chan, D. C., Chutkowski, C. T., & Kim, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15613 · Cited by 477
Collins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
The structural biology of type I viral membrane fusion
Colman, P. M., & Lawrence, M. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1076 · Cited by 454
McLellan, J. S., Yang, Y., Graham, B. S., & Kwong, P. D. (2011) · Journal of Virology · doi:10.1128/jvi.00555-11 · Cited by 436
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Bosch, B. J., Martina, B. E. E., van der Zee, R., Lepault, J., Haijema, B. J., Versluis, C., Heck, A. J. R., de Groot, R., Osterhaus, A. D. M. E., & Rottier, P. J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400576101 · Cited by 416
Influenza hemagglutinin is spring-loaded by a metastable native conformation
Carr, C. M., Chaudhry, C., & Kim, P. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14306 · Cited by 401
Protein Design of an HIV-1 Entry Inhibitor
Root, M. J., Kay, M. S., & Kim, P. S. (2001) · Science · doi:10.1126/science.1057453 · Cited by 391
Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins
McLellan, J. S., Ray, W. C., & Peeples, M. E. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-38919-1_4 · Cited by 380
The Many Mechanisms of Viral Membrane Fusion Proteins
Earp, L. J., Delos, S. E., Park, H. E., & White, J. M. (2004) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26764-6_2 · Cited by 379
AVPpred: collection and prediction of highly effective antiviral peptides.
Thakur, N., Qureshi, A., & Kumar, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks450 · Cited by 324
Structural characterization of the human respiratory syncytial virus fusion protein core
Zhao, X., Singh, M., Malashkevich, V. N., & Kim, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260499197 · Cited by 291
Hydrocarbon Stapled Peptides as Modulators of Biological Function
Cromm, P. M., Spiegel, J., & Grossmann, T. N. (2015) · ACS Chemical Biology · doi:10.1021/cb501020r · Cited by 290
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution
Malashkevich, V. N., Schneider, B. J., McNally, M. L., Milhollen, M. A., Pang, J. X., & Kim, P. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2662 · Cited by 261
Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Domachowske, J. B., & Rosenberg, H. F. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.298 · Cited by 260
Metadata
- Authors
- Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., & Petteway, S. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-03-05
- Volume
- 93
- Issue
- 5
- Pages
- 2186-2191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2012735516
- Cited by
- 336
- References
- 31
- FWCI
- 13.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.